Literature DB >> 26908492

Increased Vancomycin Exposure and Nephrotoxicity in Children: Therapeutic Does Not Mean Safe.

Kevin J Downes1, Stuart L Goldstein2, Alexander A Vinks3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 26908492      PMCID： PMC4765492          DOI： 10.1093/jpids/piu122

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


× No keyword cloud information.
  10 in total

1.  3-5 year longitudinal follow-up of pediatric patients after acute renal failure.

Authors:  D J Askenazi; D I Feig; N M Graham; S Hui-Stickle; S L Goldstein
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

2.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

3.  Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months.

Authors:  Shina Menon; Eric S Kirkendall; Hovi Nguyen; Stuart L Goldstein
Journal:  J Pediatr       Date:  2014-06-11       Impact factor: 4.406

4.  Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First 7 Days of Therapy Associated With Acute Kidney Injury in Children?

Authors:  Chad A Knoderer; Kristen R Nichols; Kelsey C Lyon; Megan M Veverka; Amy C Wilson
Journal:  J Pediatric Infect Dis Soc       Date:  2013-11-11       Impact factor: 3.164

5.  Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.

Authors:  Susan McKamy; Elvin Hernandez; Maximillian Jahng; Tiffany Moriwaki; Audra Deveikis; Jennifer Le
Journal:  J Pediatr       Date:  2011-03       Impact factor: 4.406

6.  Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001.

Authors:  Shirley Hui-Stickle; Eileen D Brewer; Stuart L Goldstein
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

7.  Acute kidney injury during vancomycin therapy in critically ill children.

Authors:  Balagangadhar R Totapally; Jacqueline Machado; Helen Lee; Ana Paredes; Andre Raszynski
Journal:  Pharmacotherapy       Date:  2013-03-21       Impact factor: 4.705

8.  Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.

Authors:  Yoshihiro Nishino; Shigekazu Takemura; Yukiko Minamiyama; Kazuhiro Hirohashi; Tetsuya Ogino; Masayasu Inoue; Shigeru Okada; Hiroaki Kinoshita
Journal:  Free Radic Res       Date:  2003-04

9.  Pediatric acute kidney injury assessed by pRIFLE as a prognostic factor in the intensive care unit.

Authors:  Nilzete Bresolin; Aline Patrícia Bianchini; Clarissa Alberton Haas
Journal:  Pediatr Nephrol       Date:  2012-11-24       Impact factor: 3.714

10.  Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.

Authors:  Jennifer Le; Pamela Ny; Edmund Capparelli; James Lane; Becky Ngu; Richard Muus; Gale Romanowski; Tiana Vo; John Bradley
Journal:  J Pediatric Infect Dis Soc       Date:  2014-11-03       Impact factor: 3.164
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.